chr2-178611379-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6
The NM_001267550.2(TTN):c.50850C>A(p.Asp16950Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,612,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.50850C>A | p.Asp16950Glu | missense_variant | 269/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.50850C>A | p.Asp16950Glu | missense_variant | 269/363 | 5 | NM_001267550.2 | ENSP00000467141 | P1 | |
TTN-AS1 | ENST00000659121.1 | n.502+13698G>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 151972Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000565 AC: 14AN: 247650Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134358
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1460642Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726620
GnomAD4 genome AF: 0.000184 AC: 28AN: 152090Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74328
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 29, 2023 | - - |
TTN-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 20, 2023 | The TTN c.50850C>A variant is predicted to result in the amino acid substitution p.Asp16950Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.074% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179476106-G-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 04, 2016 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2018 | The p.D7885E variant (also known as c.23655C>A), located in coding exon 96 of the TTN gene, results from a C to A substitution at nucleotide position 23655. The aspartic acid at codon 7885 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species; however, glutamic acid is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at